Make your money go further for just 25p per day

AIM IHT

Coronavirus: potential winners from the almost-pandemic

Coronavirus microscopic image

If there is one positive from the outbreak of the coronavirus – which has spread alarmingly quickly since it first emerged in China at the end of last year – it is that global healthcare systems have been alerted to the need for better contamination control.


It’s hardly surprising therefore, that the share price of Tristel (LON: TSTL), a specialist manufacturer of infection prevention and contamination control products, has climbed to new highs over recent weeks. It could be a big long-term winner from greater investment in global infection prevention.

Tristel’s proprietary chlorine dioxide formulation was first developed in 1993 for the disinfection of flexible endoscopes, replacing then-gold-standard glutaraldehyde, a substance known to be toxic. Originally used in water treatment and food…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Tristel

Cracking results | Questionable shareholder value

26/02/2024 · Company Insights

News covered here include cracking results from a highly-rated provider of infection prevention products, which has…


Paddling furiously, to go backwards!

23/01/2024 · Company Insights

A popular AIM company covered here is struggling to make a return on substantial revenue –…


More Company Insights

Rocketing share price

Stonking Small Cap: still on the fast track!

24/04/2024

Poorly worded | Sector winner | Improving returns

Sign-up to our free email updates

SIGN UP